Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Buy
81,160
+69,777
+613% +$2.81M 0.05% 559
2026
Q1
$377K Buy
11,383
+4,406
+63% +$143K 0.01% 2282
2025
Q4
$228K Buy
+6,977
New +$172K 0.01% 2295
2025
Q2
Sell
-23,111
Closed -$428K 2352
2025
Q1
$428K Buy
23,111
+5,805
+34% +$105K 0.02% 1139
2024
Q4
$285K Buy
+17,306
New +$245K 0.02% 1268
2024
Q2
Sell
-13,093
Closed -$106K 1863
2024
Q1
$106K Sell
13,093
-4,927
-27% -$44.1K 0.01% 1355
2023
Q4
$123K Sell
18,020
-18,208
-50% -$101K 0.03% 1089
2023
Q3
$181K Buy
36,228
+1,268
+4% +$8.78K 0.03% 1049
2023
Q2
$319K Buy
+34,960
New +$326K 0.06% 676

Other funds holding AXGN

XTX Topco's AXGN Position: Q2 2026 in Review

XTX Topco increased its Axogen (AXGN) stake by 613% in Q2 2026, buying an estimated $2.81M and bringing the position to 81,160 shares worth $3.75M. The position accounts for 0.05% of the portfolio, ranked #559.

XTX Topco first reported a position in AXGN in Q2 2023 and has held it in 9 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • XTX Topco held 81,160 shares of Axogen worth $3.75M as of Q2 2026.
  • XTX Topco bought 69,777 Axogen shares in Q2 2026, an estimated $2.81M.
  • Axogen made up 0.05% of XTX Topco's portfolio in Q2 2026, its #559 holding.
  • XTX Topco first reported a position in Axogen in Q2 2023 and has held it in 9 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.